AIM ImmunoTech and three other companies are stocks that cost less than $3 per share. Some people who work inside these companies or own a big part of them, called insiders, are buying more shares because they think the prices will go up in the future. These insiders believe that AIM ImmunoTech is working on a medicine to help people with problems after they get sick with COVID-19, and Power Solutions International makes products to help electric cars work better. Read from source...

- The title is misleading and sensationalist. It suggests that insiders are buying stocks under $3, but only one of the four companies mentioned (AIM ImmunoTech) has a share price below $3. The other three (Brightcove, Power Solutions International, and Citizens) have higher prices ranging from $8 to $27.
- The article does not provide any context or background information on the companies or their products/services. It assumes that the reader is already familiar with them or doesn't care about learning more. This makes it difficult for readers to evaluate the merits of the insider trades and the potential risks and rewards involved.
- The article focuses mostly on AIM ImmunoTech, giving it disproportionate attention compared to the other companies. It mentions a recent report on a Phase 2 study evaluating ampligen for post-COVID conditions, but does not provide any details or results of the study. It also ignores the fact that the company has been struggling financially and operationally for years, with negative earnings and cash flow. The insider trade by Director Nancy Bryan may be a sign of confidence or optimism, but it could also be a strategic move to acquire more control over the company or its assets.
- The article does not mention any other factors that could influence the stock prices of the companies, such as market trends, sector performance, competition, regulatory changes, etc. It also does not cite any sources or data to support its claims or opinions. It relies on vague phrases like "what's happening" and "check this out", without providing any meaningful insights or analysis.
- The article ends with a link to another article that lists the top 5 consumer stocks that may crash this month. This creates a sense of urgency and fear among readers, implying that they should act quickly before it's too late. However, this is a dubious strategy, as it does not reflect the actual performance or prospects of the companies mentioned in the original article. It also contradicts the positive tone of the insider trades, which suggest that the stocks are undervalued and have upside potential.